Literature DB >> 18762265

Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent?

James Alexander1, Emma McFarlane.   

Abstract

While control of intracellular pathogens, such as the protozoan Leishmania, is dependent on the generation of type-1 immune responses, the role of T helper 2 cytokines in the disease process is more controversial. Traditionally these cytokines were perceived as counter-regulating type-1 responses and promoting disease exacerbation. Nevertheless a substantial body of evidence now exists suggesting that the development of effective type-1 immunity can involve the significant involvement of the Th2 cytokines IL-4 and IL-13. This article reviews, using Leishmania species in particular, the circumstances under which these cytokines can promote protective type-1 immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762265     DOI: 10.1016/j.micinf.2008.07.038

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

1.  MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.

Authors:  Sanjay Varikuti; Gayathri Natarajan; Greta Volpedo; Bhawana Singh; Omar Hamza; Gretchen V Messick; Mireia Guerau-de-Arellano; Tracey L Papenfuss; Steve Oghumu; Abhay R Satoskar
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

3.  Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection.

Authors:  Marion M Chan; Nagasuresh Adapala; Cui Chen
Journal:  PPAR Res       Date:  2012-02-01       Impact factor: 4.964

4.  Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.

Authors:  Noushin Saljoughian; Tahereh Taheri; Farnaz Zahedifard; Yasaman Taslimi; Fatemeh Doustdari; Azam Bolhassani; Delaram Doroud; Hiva Azizi; Kazem Heidari; Mohammad Vasei; Nabiollah Namvar Asl; Barbara Papadopoulou; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18

5.  IL-4 receptor-alpha-dependent control of Cryptococcus neoformans in the early phase of pulmonary infection.

Authors:  Andreas Grahnert; Tina Richter; Daniel Piehler; Maria Eschke; Bianca Schulze; Uwe Müller; Martina Protschka; Gabriele Köhler; Robert Sabat; Frank Brombacher; Gottfried Alber
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

6.  Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.

Authors:  Wafa Kammoun-Rebai; Ikbel Naouar; Valentina Libri; Matthew Albert; Hechmi Louzir; Amel Meddeb-Garnaoui; Darragh Duffy
Journal:  BMC Infect Dis       Date:  2016-03-24       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.